ED Diabetes Screening and Outpatient Care - Aim 3
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-70
SponsorNYU Langone Health
About this trial
This goal of this NIH funded R01 study is to identify risk factors for not being able to follow-up for a new diagnosis of diabetes in the emergency department and improve linkage of these newly diagnosed patients to appropriate outpatient care. Its three aims will be accomplished through 1) a retrospective chart review of emergency department (ED) patients screened for diabetes, 2) a series of prospective qualitative interviews among ED patients with newly diagnosed diabetes who fail to follow-up for outpatient care, and 3) a simple randomized controlled trial to test the efficacy of telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.
Eligibility criteria
Qualifiers
Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5%
Residential address in New York City or Long Island
Primary language is English or Spanish
Able to provide informed consent
Disqualifiers
No prior history of diabetes
No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)
Trial design
Treatments tested in this trial
- Telehealth Bridge Visits
- Standard of Care
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
NYU Langone Health
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov